Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A serum proteome signature to predict mortality in severe COVID-19 patients

5 Jul 2021

Abstract excerpt

Here, we recorded serum proteome profiles of 33 severe COVID-19 patients admitted to respiratory and intensive care units because of respiratory failure. We received, for most patients, blood samples just after admission and at two more later time points. With the aim to predict treatment outcome, we focused on serum proteins different in abundance between the group of survivors and non-survivors. We observed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Proteomics Techniques and Applications
Share to COVID-19 Clinical Research Studies
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34226277
DOI: 10.26508/lsa.202101099

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A serum proteome signature to predict mortality in severe COVID-19 patientsPMID 34226277Read ↗

Analysis of inflammatory protein profiles in the circulation of COVID-19 patients identifies patients with severe disease phenotypesSemantic proximity Read ↗

Mapping the Serum Proteome of COVID-19 Patients; Guidance for Severity AssessmentSemantic proximity Read ↗

Circulating proteins to predict adverse COVID-19 outcomesSemantic proximity Read ↗

Analysis of inflammatory protein profiles in the circulation of COVID-19 patients identifies patients with severe disease phenotypes.Semantic proximity Read ↗

Identification of Potential Biomarkers to Predict Organ Morbidity in COVID-19: A Repository Based Proteomics PerspectiveSemantic proximity Read ↗

A time-resolved proteomic and diagnostic map characterizes COVID-19 disease progression and predicts outcomeSemantic proximity Read ↗

Combination of WFDC2, CHI3L1, and KRT19 in Plasma Defines a Clinically Useful Molecular Phenotype Associated with Prognosis in Critically Ill COVID-19 Patients.Semantic proximity Read ↗

Plasma proteomics identify potential severity biomarkers from COVID‐19 associated networkSemantic proximity Read ↗

A proteomic survival predictor for COVID-19 patients in intensive careSemantic proximity Read ↗

High-resolution longitudinal serum proteome trajectories in COVID-19 reveal patients-specific seroconversionSemantic proximity Read ↗

Longitudinal plasma proteomic analysis of 1117 hospitalized patients with COVID-19 identifies features associated with severity and outcomesSemantic proximity Read ↗

Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS InvestigationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.